Cardioembolic stroke in Chagas cardiomyopathy: the interplay between apical aneurysm, left ventricular thrombus and

Julia Teixeira Tupinambás1, Manoel Otavio C Rocha1,2, Thais Aparecida R Lage1

  • 1Post Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Insights

In Chagas cardiomyopathy (CCM), apical aneurysms increase stroke risk primarily through left ventricular thrombus formation. Prior cardioembolic stroke indicates a higher risk of recurrence, guiding targeted prevention strategies.

Area of Science:

  • Cardiology
  • Neurology
  • Infectious Diseases

Background:

  • Apical aneurysm is a known complication of Chagas cardiomyopathy (CCM).
  • The independent contribution of apical aneurysm to cardioembolic (CE) stroke and its underlying mechanisms in CCM are not fully understood.
  • Understanding these associations is crucial for effective stroke prevention in CCM patients.

Purpose of the Study:

  • To evaluate the association between apical aneurysm and CE stroke in patients with CCM.
  • To assess the prognostic implications of CE stroke in this population.
  • To elucidate the mechanisms linking apical aneurysm to CE stroke.

Main Methods:

  • Prospective cohort study of 518 CCM patients.
  • Baseline assessments included clinical, electrocardiographic, and echocardiographic evaluations.
  • Logistic regression, genetic matching, and causal mediation analyses were used to assess stroke associations and the role of left ventricular (LV) thrombus.

Main Results:

  • Apical aneurysm was significantly associated with CE stroke when using genetic matching, with 63.3% of this association mediated by LV thrombus.
  • Prior CE stroke and LV thrombus were independent predictors of prior CE stroke.
  • Neither prior CE stroke nor apical aneurysm predicted mortality or heart transplantation, but incident CE stroke was linked to prior CE stroke and LV thrombus.

Conclusions:

  • Cardioembolic stroke in CCM is predominantly driven by LV thrombus formation.
  • Apical aneurysm contributes to embolic risk primarily by promoting thrombus formation.
  • Identifying LV thrombus and implementing anticoagulation are key for targeted stroke prevention in CCM.
Abstract

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...